HIGHLIGHTS
- who: Delaram Poormoghadam and colleagues from the University of Amsterdam, Amsterdam, Netherlands Cellular and Molecular Research Center, Iran University of Medical Sciences, Tehran, Iran have published the article: Fingolimod Nanoemulsions at Different Particle Sizes Define the Fate of Spinal Cord Injury Recovery, in the Journal: BioMed Research International 90 ⁎⁎ of 16/08/2022
- what: The main focus of SCI treatment is to counteract the cascade of secondary injury mechanisms.
- how: The results indicated that nanocarriers and free FTY-720 enhanced NSC viability compared with the control group. The authors proposed fingolimod (FTY-720 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.